Associate Professor Lisa Zhuoting Zhu, head of ophthalmic epidemiology at CERA, is one of the leading authors on the paper published in Nature Medicine. She says this technology is making disease diagnosis more efficient, particularly in remote or regional communities.

“This technology will be a real benefit to public health,” says Zhu. “Patients would be able to get information about their health instantly and start interventions as soon as possible instead of waiting for more time-consuming test results.”